Scarica l'app Stockscreener
2.08
1.42%
-0.03
Dopo l'orario di chiusura:
2.19
0.11
+5.29%
Precedente Chiudi:
$2.11
Aprire:
$2.06
Volume 24 ore:
183.30K
Relative Volume:
0.08
Capitalizzazione di mercato:
$7.44M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-12.97%
1M Prestazione:
-35.60%
6M Prestazione:
-90.69%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.06
$2.27
Intervallo di 1 settimana:
$2.06
$2.38
Portata 52W:
$1.51
$323.25
Psyence Biomedical Ltd Stock (PBM) Company Profile
Nome
Psyence Biomedical Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PBM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
2.08 | 7.44M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.76 | 103.76B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.19 | 78.27B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
620.16 | 36.92B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.62 | 29.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.30 | 27.55B | 3.30B | -501.07M | 1.03B | -2.1146 |
Psyence Biomedical Ltd Borsa (PBM) Ultime notizie
Psyence Biomedical Issues Pre-Funded Share Purchase Warrant - TipRanks
Psyence Biomed Announces Closing of $2.0 Million Private Placement - GlobeNewswire
Psyence Biomed (PBM) Raises $2M in Private Placement with Warrant Coverage, Led by H.C. Wainwright - StockTitan
Psyence Biomedical Regains Nasdaq Compliance, Fortifying Market Position - Yahoo Finance
Psyence Biomed announces $2 million private placement By Investing.com - Investing.com Nigeria
PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan
Psyence Unveils Private Placement - Baystreet.ca
Psyence Biomed announces $2 million private placement - Investing.com
Psyence Biomed Announces $2.0 Million Private Placement - The Manila Times
Psyence Biomed Secures $2M Private Placement with Strategic Warrant Offering - StockTitan
Psyence Biomedical Achieves Full Nasdaq Compliance, Advances Clinical Trial Plans with $5.6M War Chest - StockTitan
US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' - Benzinga
Psyence Biomedical Signs Exclusive Licensing Agreement with Optimi Health - TipRanks
Psyence Biomedical Advances in Phase IIb Psilocybin Clinical Trial - TipRanks
Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial - The Manila Times
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed's Phase IIb Palliative Care Trial - Newsfile
Psyence Biomedical executes binding agreements with Optimi Health - Yahoo Finance
Psyence Biomedical stock soars on binding agreements with Optimi Health - MSN
Psyence Biomed Executes Binding Agreements with Optimi Health Corp - Marketscreener.com
Psyence Biomed Executes Binding Agreements with Optimi Health Corp. - The Manila Times
Psyence Biomed Secures Landmark Global Psilocybin Supply Deal for Palliative Care Drug Development - StockTitan
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle - EIN News
Psyence Biomedical Boosts Equity to Meet Nasdaq Rules - TipRanks
Psyence Biomedical Revises Debt-for-Equity Deal - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress By Investing.com - Investing.com Canada
Psyence Biomed Strengthens Position with Valuable Stake and Trials - TipRanks
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress - The Manila Times
Psyence Biomedical issues letter to shareholders - TipRanks
Psyence Biomedical Ltd trading halted, news pending - TipRanks
Psyence Biomed granted Nasdaq listing extension By Investing.com - Investing.com Australia
Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga
Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report
Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times
Psyence Biomed granted Nasdaq listing extension - Investing.com
Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM
Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan
Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN
Psyence Biomed announces share consolidation date - Investing.com India
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation - The Manila Times
Psyence Biomedical Implements 1-for-75 Share Consolidation to Meet Nasdaq Requirements | PBM Stock News - StockTitan
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq - The Manila Times
Psyence Biomedical Shareholders Approve 75:1 Stock Split Amid Nasdaq Compliance Challenge | PBM Stock News - StockTitan
Psyence Biomedical Ltd Azioni (PBM) Dati Finanziari
Non sono disponibili dati finanziari per Psyence Biomedical Ltd (PBM). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):